Cracks in EU "single market"? Medtech industry becomes increasingly frustrated
This article was originally published in Clinica
Executive Summary
Differences in national registration and vigilance requirements, two of the cornerstones of EU medtech regulation, are becoming increasingly prevalent and undermining the single market concept. Representatives of several medtech consultancies, who have a good overview of the EU picture, are starting to express their concerns publicly.